Queen Mary University of London: New Method of Measuring Tumour Infiltrating Lymphocytes Predicts Long Term Outcomes for a Type of Early Breast Cancer
July 11, 2024
July 11, 2024
LONDON, England, July 11 (TNSres) -- Queen Mary University of London issued the following news:
* * *
Researchers from Queen Mary University London and Emory University used a novel AI-based analytic tool to better understand how tumour infiltrating lymphocytes (TILs) can predict which cases of Ductal Carcinoma in Situ (DCIS) would go on to become invasive breast cancer.
* * *
DCIS is a form of early breast cancer, where some cells in the linin . . .
* * *
Researchers from Queen Mary University London and Emory University used a novel AI-based analytic tool to better understand how tumour infiltrating lymphocytes (TILs) can predict which cases of Ductal Carcinoma in Situ (DCIS) would go on to become invasive breast cancer.
* * *
DCIS is a form of early breast cancer, where some cells in the linin . . .